Are animal models predictive for humans?
Open accessThe DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index.
Abstract
It is one of the central aims of the philosophy of science to elucidate the meanings of scientific terms and also to think critically about their application. The focus of this essay is the scientific term predict and whether there is credible evidence that animal models, especially in toxicology and pathophysiology, can be used to predict human outcomes. Whether animals can be used to predict human response to drugs and other chemicals is apparently a contentious issue. However, when one empirically analyzes animal models using scientific tools they fall far short of being able to predict human responses. This is not surprising considering what we have learned from fields such evolutionary and developmental biology, gene regulation and expression, epigenetics, complexity theory, and comparative genomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“first because referencing practices are suboptimal (compare e.g. the data and figures from [5, 72, 73, 77].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as Shanks et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulatory and research leaders are increasingly taking notice of the issue.”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Even if the design and conduct of an animal experiment are sound and standardized, the translation of its results to the clinic may fail because of disparities between the animal experimental model and the human condition.21”
From The Flaws and Human Harms of Animal Experimentation (2015) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“The response of different humans to the same drug or disease is a well-known example of this phenomenon [7-13].”
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890330516 · Cited by 2,305
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 2×
“The Olson study [78] purports (and has certainly been cited in this regard) to provide evidence of the vast predictive utility of animal models in assessing human toxicity.”
IARC monographs on the evaluation of carcinogenic risks to humans
(1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90053-7 · Cited by 1,447
Casarett and Doull's toxicology
ed, T. (2015) · Cited by 1,127
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Bruder, C. E. G., Piotrowski, A., Gijsbers, A. A. C. J., Andersson, R., Erickson, S., Diaz de Ståhl, T., Menzel, U., Sandgren, J., von Tell, D., Poplawski, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.011 · Cited by 599 · cited 1×
“The response of different humans to the same drug or disease is a wellknown example of this phenomenon [7-13].”
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599 · cited 1×
“Figures vary, and are controversial, but it now appears that apparently less than 1% of people who took rofecoxib experienced a heart attack or stroke as a result, yet it was also withdrawn [35].”
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Research works printed but not linked: 14
- Greek R Greek J Specious Science 2002 New York: Continuum Int
- Salmon W Curd M, Cover J, Norton Rational Prediction Philosophy of Science 1998 433 444
- Uehling M Microdoses of Excitement over AMS, 'Phase 0' Trials Bio-IT World 2006 2006
- Greek J Greek R What Will We Do if We Don't Experiment on Animals. Continuum 2004
- Sankar U The Delicate Toxicity Balance in Drug Discovery The Scientist 2005 19 32
- Tomatis L Wilbourn L Iversen Evaluation of carcinogenic risk to humans: the experience of IARC New Frontiers in Cancer Causation 2003 Washington, DC: Taylor and Francis 371 387
- Caldwell J Jakoby W Comparative Aspects of Detoxification in Mammals Enzymatic Basis of Detoxification 1980 1 New York: Academic Press
- Clemmensen J Hjalgrim-Jensen S Alex Pub On the absence of carcinogenicity to man of phenobarbital Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Coulston F, Shubick S 251 265
- Clayson D Coulston F, Shubick P The carcinogenic action of drugs in man and animals Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Ablex Pub 185 195
- Anisimov V Molecular and Physiological Mechanisms of Aging 2003 St Petersburg: Nauka
- Kolata G 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects New York Times. New York 1997
- Shanks N Greek R Nobis N Greek J Animals and Medicine: Do Animal Experiments Predict Human Response? Skeptic 2007 13 44 51
- Conn P Parker J Letter. Animal research wars Skeptic 2007 13 18 19
- Morange M A successful form for reductionism The Biochemist 2001 23 37 39
Cited by
Items 101–200 of 778
Mathematical Models of Organoid Cultures
Montes-Olivas, S., Marucci, L., & Homer, M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00873 · Cited by 80
“…reactions but are limited by the differences between animal and human structural physiology; furthermore, in vivo systems are complex to analyze, due to interactions and feedback across cell types, regulation levels, and internal and external environments (Hartung, 2008; Shanks et al., 2009).”
BackgroundThe comet assay in animal models: From bugs to whales – (Part 2 Vertebrates)
Gajski, G., Žegura, B., Ladeira, C., Novak, M., Šrámková, M., Pourrut, B., Bo’, C. D., Milić, M., Gützkow, K. B., Costa, S., et al. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.04.002 · Cited by 81
Forest, V. (2022) · Nanomaterials · doi:10.3390/nano12081346 · Cited by 79
The Nuremberg Code subverts human health and safety by requiring animal modeling
Greek, R., Pippus, A., & Hansen, L. A. (2012) · BMC Medical Ethics · doi:10.1186/1472-6939-13-16 · Cited by 78
“We will now bring the reader into the current scientific environment as it relates to our topic [30,44-49].”
BackgroundSelf-citationA microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77
Liver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75
Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 75
In Vitro Immune Organs-on-Chip for Drug Development: A Review
Shanti, A., Teo, J., & Stefanini, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040278 · Cited by 65
Organoid Technology: Current Standing and Future Perspectives
Shariati, L., Esmaeili, Y., Javanmard, S. H., Bidram, E., & Amini, A. (2021) · Stem Cells · doi:10.1002/stem.3379 · Cited by 73
Gougis, P., Hilmi, M., Géraud, A., Mir, O., & Funck‐Brentano, C. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103342 · Cited by 72
Zhang, Y., Zheng, Z., Zhu, S., Xu, L., Zhang, Q., Gao, J., Ye, M., Shen, S., Xing, J., Wu, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202416267 · Cited by 72
Cattane, N., Vernon, A. C., Borsini, A., Scassellati, C., Endres, D., Capuron, L., Tamouza, R., Benros, M. E., Leza, J. C., Pariante, C. M., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.02.002 · Cited by 64
Surface functionalisation of nanodiamonds for human neural stem cell adhesion and proliferation
Taylor, A. C., González, C. H., Miller, B. S., Edgington, R. J., Ferretti, P., & Jackman, R. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-07361-y · Cited by 71
Helminth Therapy – From the Parasite Perspective
Sobotková, K., Parker, W., Levá, J., Růžková, J., Lukeš, J., & Jirků‐Pomajbíková, K. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.04.009 · Cited by 70
“However, the variable approaches used, and the inevitable difference between disease models and disease in humans, make it dif fi cult to know whether the results from such studies can predict human outcomes [50,51].”
BackgroundSorption and release of small molecules in PDMS and COC for Organs on chip
Grindulis, K., Matusevica, N. G., Kozlova, V., Rimša, R., Klavins, K., & Mozoļevskis, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-97111-2 · Cited by 69
Ethics commentary: subjects of knowledge and control in field primatology
Malone, N., Fuentes, A., & White, F. (2010) · American Journal of Primatology · doi:10.1002/ajp.20840 · Cited by 69
“Although the very ability of animal models to accurately predict biological results in human clinical trials is questioned [Greek & Greek, 2000; Shanks et al., 2009; Sharpe, 1988], practitioners are accountable for their research protocols and, at least in theory, legally comply to strict…”
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
Nicotine replacement therapy for smoking cessation during pregnancy
Bar‐Zeev, Y., Lim, L. L., Bonevski, B., Gruppetta, M., & Gould, G. S. (2018) · Medical Journal of Australia · doi:10.5694/mja17.00446 · Cited by 66
Engineering in vitro models of hepatofibrogenesis
Mazza, G., Al‐Akkad, W., & Rombouts, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.018 · Cited by 66
Modelling microglial function with induced pluripotent stem cells: an update
Pocock, J. M., & Piers, T. M. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0030-3 · Cited by 66
Engineered organoids for biomedical applications
de Barros, N. R., Wang, C., Maity, S., Peirsman, A., Nasiri, R., Herland, A., Ermis, M., Kawakita, S., de Carvalho, B. G., Kouchehbaghi, N. H., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115142 · Cited by 63
Scarano, A., Khater, A. G. A., Gehrke, S. A., Inchingolo, F., & Tari, S. R. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15040083 · Cited by 63
“Contrastingly, using large animal models (e.g., sheep, pigs, primates, and dogs) is still essential since they are clinically similar to humans in various aspects [17].”
Use of stem cells as alternative methods to animal experimentation in predictive toxicology
Kim, T., Che, J., & Yun, J.-W. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.03.016 · Cited by 63
Study of Longitudinal Aging in Mice: Presentation of Experimental Techniques
Palliyaguru, D. L., Teixeira, C. V. L., Duregon, E., Germanio, C. D., Alfaras, I., Mitchell, S. J., Navas‐Enamorado, I., Shiroma, E. J., Studenski, S. A., Bernier, M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa285 · Cited by 64
“However, the use of mice as reliable models of human aging has been greatly hindered by the lack of a comprehensive analysis of normal aging across sex and strains (38,39).”
BackgroundMicrodissected “cuboids” for microfluidic drug testing of intact tissues
Horowitz, L. F., Rodriguez, A. D., Au-Yeung, A., Bishop, K. W., Barner, L. A., Mishra, G., Raman, A., Delgado, P., Liu, J. T. C., Gujral, T. S., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc00801j · Cited by 62
Mice in translational neuroscience: What R we doing?
Azkona, G., & Sánchez‐Pernaute, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102330 · Cited by 63
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Bieghs, L., Johnsen, H. E., Maes, K., Menu, E., Van Valckenborgh, E., Overgaard, M. T., Nyegaard, M., Conover, C. A., Vanderkerken, K., & De Bruyne, E. (2016) · Oncotarget · doi:10.18632/oncotarget.8982 · Cited by 61
Rodrigues, R. M., Kock, J. D., Branson, S., Vinken, M., Meganathan, K., Chaudhari, U., Sachinidis, A., Govaere, O., Roskams, T., Boe, V. D., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0157 · Cited by 61
Sutherland, J. J., Jolly, R. A., Goldstein, K. M., & Stevens, J. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004847 · Cited by 61
Characterization of vascular permeability using a biomimetic microfluidic blood vessel model
Thomas, A., Wang, S., Sohrabi, S., Orr, C., He, R., Shi, W., & Liu, Y. (2017) · Biomicrofluidics · doi:10.1063/1.4977584 · Cited by 61
Relevance of bioreactors and whole tissue cultures for the translation of new therapies to humans
Peroglio, M., Gaspar, D., Zeugolis, D. I., & Alini, M. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23655 · Cited by 61
“While many studies are still performed on small rodent models, there is a large gap in the translation of successful therapies from mice to humans.(72) Importantly not only breeds play a role, but even environmental factors such as nutrition, bedding and exposure to light have been shown to have a strong impact on the…”
BackgroundMicrofluidic platforms for modeling biological barriers in the circulatory system
Yu, F., Kumar, N. D. O. S., Choudhury, D., Foo, L. C., & Ng, S. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.036 · Cited by 61
‘Extreme’ organisms and the problem of generalization: interpreting the Krogh principle
Green, S., Dietrich, M. R., Leonelli, S., & Ankeny, R. A. (2018) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-018-0231-0 · Cited by 61
Keuper-Navis, M., Walles, M., Poller, B., Myszczyszyn, A., van der Made, T. K., Donkers, J., Eslami Amirabadi, H., Wilmer, M. J., Aan, S., Spee, B., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106853 · Cited by 52
Integrated Electrochemical and Optical Biosensing in Organs‐on‐Chip
Tawade, P. V., & Mastrangeli, M. (2023) · ChemBioChem · doi:10.1002/cbic.202300560 · Cited by 60
Lee, S. Y., & Yoo, S. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-023-00796-8 · Cited by 60
“A previous study found that 43% of clinical toxicities were not identified in animal studies for 64 marketed drugs [10].”
BackgroundNonviral delivery systems for antisense oligonucleotide therapeutics
Huang, S. Q., Hao, X., Li, Y., Wu, J., Xiang, D., & Luo, S. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00292-4 · Cited by 59
Is the use of sentient animals in basic research justifiable?
Greek, R., & Greek, J. (2010) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-5-14 · Cited by 54
“humans?” [1], in this essay we break the problem down into one manageable question while acknowledging that the issue per se is much larger and that this essay is but one component of many.”
BackgroundInfluentialSelf-citationWeaver, S. R., Rendeiro, C., McGettrick, H. M., Philp, A., & Lucas, S. J. E. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02247-8 · Cited by 59
Human cells with osteogenic potential in bone tissue research
Dvorakova, J., Wiesnerova, L., Chocholata, P., Kulda, V., Landsmann, L., Cedikova, M., Kripnerova, M., Eberlova, L., & Babuska, V. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01096-w · Cited by 58
“The fact that they are human cells eliminates differences in cell behavior under experimental conditions that would occur when using cell lines from different animal models [166, 167].”
BackgroundPastorino, P., Prearo, M., & Barceló, . (2024) · Green Analytical Chemistry · doi:10.1016/j.greeac.2024.100096 · Cited by 58
“Historically, animal testing with vertebrates was seen as the most reliable method for predicting the impact of substances on humans and the environment [20, 21].”
Vanparys, P., Corvi, R., Aardema, M. J., Gribaldo, L., Hayashi, M., Hoffmann, S., & Schechtman, L. M. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.02.001 · Cited by 58
Tian, L., Gao, J., Garcia, I. M., Chen, H. J., Castaldi, A., & Chen, Y. (2020) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.399 · Cited by 58
Khan, I., Preeti, K., Kumar, R., Khatri, D. K., & Singh, S. B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109793 · Cited by 57
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
Sweiti, H., Ekwunife, O. I., Jaschinski, T., & Lhachimi, S. K. (2017) · Current Therapeutic Research · doi:10.1016/j.curtheres.2017.01.007 · Cited by 56
Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
Feng, F., Shen, B., Mou, X., Li, Y., & Li, H. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.03.007 · Cited by 55
Olivares‐Morales, A., Hatley, O. J. D., Turner, D. B., Galetin, A., Aarons, L. J., & Rostami‐Hodjegan, A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1193-2 · Cited by 54
Combination Therapy for Invasive Fungal Infections
Livengood, S. J., Drew, R. H., & Perfect, J. R. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00369-4 · Cited by 54
In vitro Models of the Small Intestine for Studying Intestinal Diseases
Jung, S.-M., & Kim, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.767038 · Cited by 54
Mitochondrial Protein Homeostasis and Cardiomyopathy
Wachoski-Dark, E., Zhao, T., Khan, A., Shutt, T. E., & Greenway, S. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063353 · Cited by 52
Galangin’s potential as a functional food ingredient
Mak, K., Tan, J.-J., Marappan, P., Balijepalli, M. K., Choudhury, H., Ramamurthy, S., & Pichika, M. R. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.054 · Cited by 52
Recent progress of iPSC technology in cardiac diseases
Funakoshi, S., & Yoshida, Y. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03172-3 · Cited by 52
Emerging Bioelectronic Strategies for Cardiovascular Tissue Engineering and Implantation
Cox‐Pridmore, D. M., de Castro, F. A., Silva, S. R. P., Camelliti, P., & Zhao, Y. (2022) · Small · doi:10.1002/smll.202105281 · Cited by 52
Modeling the hypothalamus-pituitary-adrenal axis: A review and extension
Hosseinichimeh, N., Rahmandad, H., & Wittenborn, A. K. (2015) · Mathematical Biosciences · doi:10.1016/j.mbs.2015.08.004 · Cited by 51
The epistemic superiority of experiment to simulation
Roush, S. (2017) · Synthese · doi:10.1007/s11229-017-1431-y · Cited by 50
van Berlo, D., van de Steeg, E., Amirabadi, H. E., & Masereeuw, R. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.05.001 · Cited by 50
Contemporary Animal Models For Human Gene Therapy Applications
Gopinath, C., Nathar, T. J., Ghosh, A., Hickstein, D. D., & Nelson, E. J. R. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150929110424 · Cited by 49
“Sometimes, mouse models do not entirely mirror phenotypic features of human diseases in which case it becomes difficult to interpret and correlate crucial findings for human applications [37, 38].”
BackgroundOnline and in situ analysis of organs-on-a-chip
Santbergen, M. J. C., van der Zande, M., Bouwmeester, H., & Nielen, M. W. F. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.04.006 · Cited by 49
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
Marei, I., Samaan, T. M. A., Al-Quradaghi, M. A., Farah, A., Mahmud, S. H., Ding, H., & Triggle, C. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.847554 · Cited by 49
Chen, Y., Hsu, P., Hsiao, C., & Lin, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122937 · Cited by 48
Bannuscher, A., Karkossa, I., Buhs, S., Nollau, P., Kettler, K., Balaș, M., Dinischiotu, A., Hellack, B., Wiemann, M., Luch, A., et al. (2019) · Nanotoxicology · doi:10.1080/17435390.2019.1684592 · Cited by 48
“2019 Informa UK Limited, trading as Taylor & Francis Group species (Olson et al. 2000; Wall and Shani 2008; Shanks et al. 2009).”
BackgroundShahpouri, M., Adili-Aghdam, M. A., Mahmudi, H., Jaymand, M., Amoozgar, Z., Akbari, M., Hamblin, M. R., & Jahanban‐Esfahlan, R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.009 · Cited by 48
Safety assessment of adjuvanted vaccines: Methodological considerations
Silva, F. T. D., Pasquale, A. D., Yarzábal, J. P., & Garçon, N. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1043501 · Cited by 47
“Thus it is only when a new vaccine reaches the clinic that the reactogenicity and safety profile can be definitively explored.(40) Various regulatory guidelines for toxicological and pharmacological testing of new vaccines and adjuvants exist.”
BackgroundRossi, O., Citiulo, F., & Mancini, F. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1780092 · Cited by 47
“cutaneous/local adverse events being the best predicted).(62) The instantaneous reactogenicity and the post-vaccination fever response that could translate in rejection of the vaccine (at least for use in children) are more”
BackgroundMicrofluidics for interrogating live intact tissues
Horowitz, L. F., Rodriguez, A. D., Ray, T., & Folch, A. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-0164-0 · Cited by 42
Organoids: A new approach in toxicity testing of nanotherapeutics
Nabi, S. U., Ali, S. I., Rather, M. A., Sheikh, W. M., Altaf, M., Singh, H., Mumtaz, P. T., Mishra, N. C., Nazir, S. U., & Bashir, S. M. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4206 · Cited by 47
“There are serious constraints to animal studies used for preclinical experiments because this can be costly, harder to monitor, and often struggle to realistically simulate metabolic rate, drug efficacy, and immune function (Dobrolecki et al., 2016; Shanks et al., 2009).”
BackgroundEnzymatic Biotesting: Scientific Basis and Application
Esimbekova, E. N., Torgashina, I. G., Kalyabina, V. P., & Kratasyuk, V. A. (2021) · Contemporary Problems of Ecology · doi:10.1134/s1995425521030069 · Cited by 47
“If the task is to determine the safety of water consumption by a person, then the best bioassay is that person, and anything else must be recognized only as an approximation to this bioassay (Shanks et al., 2009).”
BackgroundThe ethical dimension in published animal research in critical care: the public face of science
Bara, M., & Joffe, A. R. (2014) · Critical Care · doi:10.1186/cc13694 · Cited by 47
“The alternative to this explanation is that responses to interventions are different in different species due to in-principle differences in initial conditions of complex systems (the organism) resulting in different genomic (and hence functional) outcomes [46-51].”
BackgroundAnimal models and conserved processes
Greek, R., & Rice, M. J. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-40 · Cited by 47
“[14-16,18,57,58,120], despite the presence of shared physicochemical properties and conserved processes.”
BackgroundInfluentialSelf-citationYe, L., Tang, X., Zhong, J., Li, W., Xu, T. S., Xiang, C. J., Gu, J., Feng, H., Luo, Q., & Wang, G. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14652 · Cited by 46
“15 To that end, our research is exploring an inflammation-mediated WMH model using collagenase, 16 facilitating precise and quantitative modeling.”
MethodIntegrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro
den Hof, W. F. P. M. V., Ruiz‐Aracama, A., Summeren, A. V., Jennen, D. G. J., Gaj, S., Coonen, M. L. J., Brauers, K. J. J., Wodzig, W. K. W. H., van Delft, J. H. M., & Kleinjans, J. C. S. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.12.016 · Cited by 47
Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
Choudhary, S., Ramasundaram, P., Dziopa, E., Mannion, C. M., Kissin, Y., Tricoli, L., Albanese, C., Lee, W., & Zilberberg, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-36424-x · Cited by 46
Arqub, S. A., Gandhi, V., Iverson, M. G., Ahmed, M., Kuo, C., Mu, J., Dutra, E. H., & Uribe, F. A. (2021) · Progress in Orthodontics · doi:10.1186/s40510-021-00349-5 · Cited by 46
Multi-organ-on-chip approach in cancer research
Żuchowska, A., & Skorupska, S. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100014 · Cited by 46
Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics
Jackson, S. R., Flemming, J. P., Karagoz, K., Wermuth, P. J., & Mahoney, M. G. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.70017 · Cited by 46
“…animal models, usually rodent-based, can address some shortcomings of 2D cell culture systems in replicating the TME in vitro, they entail significant investments of time and cost with no guarantee that the results will be replicated in human trials (Doncheva et al., 2021; Shanks et al., 2009).”
BackgroundVaresano, S., Zocchi, M. R., & Poggi, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00998 · Cited by 45
Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
Szebeni, J., & Bawa, R. (2020) · Biomedicines · doi:10.3390/biomedicines8040082 · Cited by 45
“Beside advantages, all animal models have certain limitations, and to decide which animal model is ideal to predict human responses to drugs has always been a contentious issue [119,121].”
BackgroundMethodXi, W., Saleh, J., Yamada, A., Tomba, C., Mercier, B., Janel, S., Dang, T., Soleilhac, M., Djemat, A., Wu, H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121380 · Cited by 46
Animal models of cardiac arrest: A systematic review of bias and reporting
Fabian-Jessing, B. K., Vallentin, M. F., Secher, N., Hansen, F. B., Dezfulian, C., Granfeldt, A., & Andersen, L. W. (2018) · Resuscitation · doi:10.1016/j.resuscitation.2018.01.047 · Cited by 45
Aderounmua, A., Omonisib, A., Akingbasotec, J., Makanjuolad, M., Bejide, R. A., Orafidiya, L., & Adelusolae, K. (2013) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v10i3.28 · Cited by 45
Morgan, P. T., & Breen, L. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00574-z · Cited by 44
Are animal models predictive for human postmortem muscle protein degradation?
Ehrenfellner, B., Zissler, A., Steinbacher, P., Monticelli, F. C., & Pittner, S. (2017) · International Journal of Legal Medicine · doi:10.1007/s00414-017-1643-1 · Cited by 44
“Animal models, on the other hand, are successfully used in many fields of science and are regularly used in basic research to reflect humans in a standardized manner [19].”
BackgroundLi, Y., Hu, C., Wang, P., Liu, Y., Wang, L., Pi, Q., Gong, Z., Yang, X., Mak, M., & Wu, Y. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0458-2 · Cited by 44
Khan, I., Kaur, S., Rishi, A. K., Boirie, B., Aare, M., & Singh, M. S. (2024) · Biomedicines · doi:10.3390/biomedicines12071442 · Cited by 44
Baijnath, S., Soobryan, N., Mackraj, I., Gathiram, P., & Moodley, J. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.08.021 · Cited by 43
Hsia, G. S. P., Esposito, J., Rocha, L. A., Ramos, S. L. G., & Okamoto, O. K. (2021) · Stem Cells International · doi:10.1155/2021/6632160 · Cited by 43
“Also, regular cell culture systems do not capture the organ’s complexity and the access to material is difficult [101].”
BackgroundTranslational Block in Stroke: A Constructive and “Out-of-the-Box” Reappraisal
Lourbopoulos, A. I., Mourouzis, I. S., Xinaris, C., Zerva, N., Filippakis, K., Pavlopoulos, A., & Pantos, C. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.652403 · Cited by 42
Pharmacokinetics‐On‐a‐Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME
Ramadan, Q., Fardous, R. S., Hazaymeh, R., Alshmmari, S. K., & Zourob, M. M. (2021) · Advanced Biology · doi:10.1002/adbi.202100775 · Cited by 42
Truisi, G. L., Consiglio, E. D., Parmentier, C., Savary, C. C., Pomponio, G., Bois, F. Y., Lauer, B., Jossé, R., Hewitt, P. G., Mueller, S. O., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.01.006 · Cited by 40
“The discrepancies can be frequently attributed to different kinetic behaviours of the compound in the different species (Shanks et al., 2009).”
A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions
Mencarelli, A., Gunawan, M., Yong, K. S. M., Bist, P., Tan, W. W. S., Tan, S. Y., Liu, M., Huang, E. K., Fan, Y., Chan, J. K. Y., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1219-210rr · Cited by 40
Extracellular vesicles and asthma: A review of the literature
Sangaphunchai, P., Todd, I., & Fairclough, L. C. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13562 · Cited by 40
Regenerative Engineering: Current Applications and Future Perspectives
Goldenberg, D., McLaughlin, C., Koduru, S. V., & Ravnic, D. J. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.731031 · Cited by 40
Gopalsamy, R. G., Barreto, P. G., Lima, B. D. S., Quintans, J. D. S. S., Araújo, A. A. D. S., Narain, N., Quintans‐Júnior, L. J., & Gurgel, R. Q. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.11.005 · Cited by 41
Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols
Conti, F., MCCUE, J., Dituro, P., Galpin, A. J., & Wood, T. R. (2024) · Nutrients · doi:10.3390/nu16152430 · Cited by 42
“Emerging results from preclinical data and animal studies provide insight into the interplay between these biochemical compounds and some of the physiological processes triggered by brain injury, however their generalisability to human cohorts remains questionable [290,291].”
BackgroundHuang, J. Y., & King, N. B. (2017) · Public Health Ethics · doi:10.1093/phe/phx013 · Cited by 39
“…only be done with great care (Geronimus, 2013); indeed, a welldeveloped ethics literature already exists on the dangers inherent in such extrapolation with regard to pharmaceuticals and other medical interventions (Shanks et al., 2009; Ioannidis, 2012; Green, 2015; Kimmelman and Henderson, 2015).”
BackgroundValtorta, S., Salvatore, D., Rainone, P., Belloli, S., Bertoli, G. R., & Moresco, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165631 · Cited by 40
Current advances of stem cell-based therapy for kidney diseases
Wong, C. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.914 · Cited by 39
Into the Depths: Techniques for in Vitro Three-Dimensional Microtissue Visualization
Kabadi, P. K., Vantangoli, M. M., Rodd, A. L., Leary, E., Madnick, S. J., Morgan, J. R., Kane, A. B., & Boekelheide, K. (2015) · BioTechniques · doi:10.2144/000114353 · Cited by 39
Seifirad, S., & Haghpanah, V. (2019) · The EPMA Journal · doi:10.1007/s13167-019-00176-z · Cited by 38
“For example, clofibrate, nafenopin, phenobarbital, and reserpine cause cancer in old but not young rats [80] [81] [82] .”
BackgroundResearch involving pregnant women: trials and tribulations
Baylis, F. E., & Halperin, S. A. (2012) · Clinical Investigation · doi:10.4155/cli.11.178 · Cited by 38
Metadata
- Authors
- Shanks, N., Greek, R., & Greek, J.
- Affiliations
- Wichita State University (US)
- Corresponding author
- Greek, Ray
- Venue
- Philosophy, Ethics, and Humanities in Medicine
- Published
- 2009-01-15
- Volume
- 4
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1747-5341 (ISSN-L)
- PMC
- PMC2642860
- OpenAlex
- W2030932194
- Cited by
- 677
- References
- 79
- Citations by year
- 2026: 18 · 2025: 38 · 2024: 53 · 2023: 43 · 2022: 66 · 2021: 69 · 2020: 69 · 2019: 64 · 2018: 67 · 2017: 47 · 2016: 37 · 2015: 35 · 2014: 19 · 2013: 21 · 2012: 13
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Philosophy Ethics and Humanities in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- animal models, predictive validity, animal-to-human extrapolation, toxicology, pathophysiology, drug response prediction, scientific terminology, epigenetics, comparative genomics, complexity theory, evolutionary biology, developmental biology, gene expression regulation
- MeSH terms
- Animals, Forecasting, Humans, Models, Animal, Animal Experimentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.